✦ LIBER ✦

Symptomatic benefit in patients with advanced non-small lung cancer (NSCLC): Experience with gemcitabine

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide and gemcitabine in advanced n

✍ Gatzemeier, O.; Manegold, C.; Eberhard, W.; Wilke, H.; Chomy, F.; Chomy, P.; Kha 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 90 KB

74 Salvage therapy with gemcitabine (GEM

✍ Crinò, L.; Mosconi, A.M.; Scagliotti, G.; De Marinis, F.; Darwish, S.; Calandri, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Second-line treatment with single-agent

✍ van Putten, J.W.G; Baas, P; Codrington, H; Kwa, H.B; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

173 Symptomatic benefit of palliative ra

✍ M. Zemanová; L. Petruželka; P. Zatloukal 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Gemcitabine and Carboplatin for Patients

✍ Manuel Dómine; Victoria Casado; Laura G. Estévez; Ana León; Jose Ignacio Martin; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 671 KB

Update on gemcitabine/carboplatin in pat

✍ Peter Harper 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 252 KB